Study questions a classic clue in canine plasmacytoma diagnosis
Bottom line
A new retrospective study in the Journal of Veterinary Diagnostic Investigation examined how often adipocytes are actually present within canine extramedullary plasma cell tumors, a feature many pathologists have treated as a helpful clue when distinguishing these tumors from other cutaneous round-cell neoplasms. Reviewing 265 tumors from a single institution, the authors found intra-tumoral adipocytes in 73 cases, or 27.5%, meaning most canine extramedullary plasma cell tumors in their dataset did not contain this feature. That challenges the idea that adipocyte entrapment is a consistently reliable hallmark and suggests it should be interpreted as supportive, not expected, when evaluating these lesions. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary pathologists and clinicians, the study is a practical reminder that absence of adipocytes shouldn’t steer a case away from plasmacytoma if the rest of the morphology fits. Canine extramedullary plasmacytomas are relatively common cutaneous tumors, usually considered low-risk overall, but they can overlap histologically with other round-cell tumors, including cutaneous histiocytoma. Recent work has also underscored the value of immunohistochemistry, with MUM1 and immunoglobulin light chains improving diagnostic sensitivity when morphology is equivocal. (merckvetmanual.com)
What to watch: Watch for whether this paper shifts pathology teaching and reporting toward treating intra-tumoral adipocytes as an inconsistent finding rather than a classic diagnostic expectation. (pmc.ncbi.nlm.nih.gov)
Key facts
- Study type
- Retrospective study
- Journal
- Journal of Veterinary Diagnostic Investigation
- Tumor type
- Canine extramedullary plasma cell tumors
- Sample size
- 265 tumors
- Finding
- Intra-tumoral adipocytes were found in 73 tumors
- Prevalence
- 27.5%
- Interpretation
- Most tumors in the dataset did not contain intra-tumoral adipocytes
- Clinical takeaway
- Absence of adipocytes should not rule out plasmacytoma if the morphology fits
A new paper in the Journal of Veterinary Diagnostic Investigation is pressing on a familiar diagnostic teaching point in canine dermatopathology: adipocytes interspersed among plasma cells have long been described as a useful clue for canine extramedullary plasma cell tumors. In a retrospective review of 265 canine extramedullary plasma cell tumors from a single institution, the authors found intra-tumoral adipocytes in just 73 cases, or 27.5%, indicating the feature is present in only a minority of tumors in this cohort. (pmc.ncbi.nlm.nih.gov)
That matters because canine extramedullary plasmacytomas are common round-cell tumors of the skin and mucocutaneous sites, and they can still create diagnostic friction, especially when morphology is atypical. Standard references describe these tumors as relatively common and generally low-risk, while older and newer literature alike show they can display a broad histologic spectrum. A 2025 PubMed-indexed study on the histologic spectrum of canine extramedullary plasmacytomas highlighted ongoing diagnostic challenges, particularly in separating them from cutaneous histiocytomas. (merckvetmanual.com)
The new adipocyte-focused study appears to narrow in on one specific assumption: that adipocytes within the tumor are usually the result of entrapped subcutaneous fat and can help distinguish plasmacytoma from other round-cell tumors. Based on the abstract provided for the paper, the investigators assessed prevalence, extent, and distribution of adipocytes across 265 cases and found them in a little more than one-quarter of tumors. The practical implication is straightforward: adipocytes may still be helpful when present, but they are far from universal. (pmc.ncbi.nlm.nih.gov)
That interpretation fits with the broader literature. Reviews of canine cutaneous round-cell neoplasms note that adipocyte entrapment can occur when tumors extend into subcutis, but this is a morphologic pattern, not a standalone diagnostic test. Meanwhile, immunophenotyping remains important when morphology is less clear. In the recent histologic-spectrum study, most canine extramedullary plasmacytomas were positive for MUM1, and combining MUM1 with immunoglobulin light-chain staining produced very high diagnostic sensitivity, outperforming the combination of MUM1 and CD79a. Earlier work also showed that these tumors commonly express lambda light chains, reinforcing the role of targeted immunohistochemistry in difficult cases. (pubmed.ncbi.nlm.nih.gov)
I didn’t find a separate press release or published expert commentary specifically reacting to this adipocyte paper. But the surrounding literature helps explain why the finding is relevant. Pathologists are often balancing subtle morphologic clues against a differential that includes histiocytoma, mast cell tumor, lymphoma, and other round-cell lesions. When one traditional clue turns out to be absent in roughly seven out of 10 cases in a single-institution series, that’s the kind of nuance that can change how residents are taught and how equivocal cases are worked up. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, especially diagnostic pathologists, oncologists, and general practitioners reviewing biopsy reports, this study supports a more cautious reading of “classic” morphologic features. If adipocytes are absent, that alone shouldn’t count strongly against extramedullary plasmacytoma. And if morphology is mixed or unusual, there’s a strong case for leaning earlier on confirmatory immunohistochemistry rather than over-weighting one histologic pattern. That’s especially relevant because, although many canine extramedullary plasmacytomas behave benignly and are often managed successfully with surgery, subsets of oral or non-cutaneous disease can show progression, making accurate classification important for case management and client counseling. (pubmed.ncbi.nlm.nih.gov)
What to watch: The next thing to watch is whether follow-up studies validate these findings across multiple institutions and whether future pathology references begin framing intra-tumoral adipocytes as an occasional supportive feature, rather than a routinely expected one, in canine extramedullary plasma cell tumors. (pmc.ncbi.nlm.nih.gov)